Role of nitric oxide, muscarinic receptors, and the ATP-sensitive K+ channel in mediating the effects of acetylcholine to mimic preconditioning in dogs

Circulation Research

Volumn 73, Issue 6, 1993, Pages 1193-1201

  Yao, Zhenhai ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Acetylcholine; ATP sensitive K+ channel; Ischemic preconditioning; Muscarinic receptor; Nitric oxide

Indexed keywords

ACETYLCHOLINE; MUSCARINIC RECEPTOR; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE FIBRILLATION; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ANIMAL; CORONARY CIRCULATION; DOGS; FEMALE; HEMODYNAMICS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NITRIC OXIDE; POTASSIUM CHANNELS; RECEPTORS, MUSCARINIC; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VENTRICULAR FIBRILLATION;

EID: 0027372247     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.73.6.1193     Document Type: Article

References (25)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
2. Downey JM. Ischemic preconditioning: nature's own cardioprotective intervention. Trends Cardiovasc Med. 1992;2:170-176.
3. Doods HN, Dammgen J, Mayer N, Rinner I. Muscarinic receptors in the heart and vascular system. Prog Pharmacol Clin Pharmacol 1989;7:47-72.
4. Gross GJ, Buck JD, Warltier DC. Transmural distribution of blood flow during activation of coronary muscarinic receptors. Am J Physiol. 1981;240:H941-H946.
5. Vegh A, Szekeres L, Parratt J. Preconditioning of the ischemie myocardium: involvement of the L-arginine nitric oxide pathway. Br J Pharmacol. 1992;107:648-652.
6. i protein coupling in preconditioning. Circulation. 1992;86(suppl 1):I-174. Abstract.
7. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A. 1993;90:347-351.
8. Yao Z, Gross GJ. Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am J Physiol. In press.
9. + channel by 5-hydroxydecanoate in guinea pig ventricular myocytes. J Pharmacol Exp Ther. 1992;260:702-708.
10. Auchampach JA, Grover GJ, Gross GJ. Blockade of ischemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res. 1992;26:1054-1062.
11. McCullough JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S, Grover GJ. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ Res. 1991;69:949-958.
12. G-Nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res. 1993;72: 387-395.
13. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 1992;70:223-233.
14. Thornton JD, Liu GS, Downey JM. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for Gi-protein mechanism. J Mol Cell Cardiol. 1993;25:311-320.
15. Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol. 1987;253:H1470-H1476.
16. Chi L, Uprichard ACG, Lucchesi BR. Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death. J Cardiovasc Pharmacol. 1990;15:452-464.
17. Bolli RM. Mechanism of myocardial "stunning." Circulation. 1990; 82:723-738.
18. Broten TP, Miyashiro JK, Moncada S, Feigl EO. Role of endothelium-derived relaxing factor in parasympathetic coronary vasodilation. Am J Physiol. 1992;262:H1579-H1584.
19. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746-752.
20. Ishii K, Chang B, Kerwin JF Jr, Huang Z-J, Murad F. N-Nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol. 1990;176:219-223.
21. Mentzer RM, Bunger R Jr, Lasley RD. Adenosine enhanced preservation of myocardial function and energetics: possible involvement of the adenosine A1 receptor system. Cardiovasc Res. 1993;27:28-35.
22. Pfaffinger PJ, Martin JM, Hunter DD, Nathanson NM, Hille B. GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature. 1985;317:536-538.
23. Murakami M, Furukawa Y, Karasawa Y, Ren L-M, Takayama S, Chiba S. Inhibition by glibenclamide of negative chronotropic and inotropic responses to pinacidil, acetylcholine, and adenosine in the isolated dog heart. J Cardiovasc Pharmacol. 1992;19:618-624.
24. Yang CM, Yeh HM, Sung TC, Chen FF, Wang YY. Characterization of muscarinic receptor subtypes in canine left ventricular membranes. J Recept Res. 1992;12:427-449.
25. + channel in guinea pig atrial cell membrane. J Gen Physiol. 1992;99:961-983.